Current status and opportunities for therapeutic drug monitoring in the treatment of tuberculosis
出版年份 2016 全文链接
标题
Current status and opportunities for therapeutic drug monitoring in the treatment of tuberculosis
作者
关键词
-
出版物
Expert Opinion on Drug Metabolism & Toxicology
Volume 12, Issue 5, Pages 509-521
出版商
Informa Healthcare
发表日期
2016-03-08
DOI
10.1517/17425255.2016.1162785
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Multi-center evaluation of a user-friendly lateral flow assay to determine IP-10 and CCL4 levels in blood of TB and non-TB cases in Africa
- (2016) Paul L.A.M. Corstjens et al. CLINICAL BIOCHEMISTRY
- Incorporating therapeutic drug monitoring into the World Health Organization hierarchy of tuberculosis diagnostics
- (2016) Samiksha Ghimire et al. EUROPEAN RESPIRATORY JOURNAL
- LC-MS/MS for Therapeutic Drug Monitoring of anti-infective drugs
- (2016) Anette Veringa et al. TRAC-TRENDS IN ANALYTICAL CHEMISTRY
- A Step toward an Optimized Rifampin Dose Completed
- (2015) Martin J. Boeree et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Determination of MIC Distribution and Epidemiological Cutoff Values for Bedaquiline and Delamanid in Mycobacterium tuberculosis Using the MGIT 960 System Equipped with TB eXiST
- (2015) Peter M. Keller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetic Modeling and Optimal Sampling Strategies for Therapeutic Drug Monitoring of Rifampin in Patients with Tuberculosis
- (2015) Marieke G. G. Sturkenboom et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Limited Sampling Strategy and Target Attainment Analysis for Levofloxacin in Patients with Tuberculosis
- (2015) Abdullah Alsultan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Decreased Osteopontin Expression as a Reliable Prognostic Indicator of Improvement in Pulmonary Tuberculosis: Impact of the Level of Interferon-γ-Inducible Protein 10
- (2015) Yunan Zhu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Linezolid tolerability in multidrug-resistant tuberculosis: a retrospective study: TABLE 1
- (2015) Mathieu S. Bolhuis et al. EUROPEAN RESPIRATORY JOURNAL
- The human immune response to tuberculosis and its treatment: a view from the blood
- (2015) Jacqueline M. Cliff et al. IMMUNOLOGICAL REVIEWS
- Predicting differential rifamycin resistance in clinical Mycobacterium tuberculosis isolates by specific rpoB mutations
- (2015) W. ElMaraachli et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000–2009
- (2015) R. van Altena et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Molecular drug susceptibility testing in the Netherlands: performance of the MTBDRplus and MTBDRsl assays
- (2015) S. O. Simons et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Disputed rpoB mutations can frequently cause important rifampicin resistance among new tuberculosis patients
- (2015) A. Van Deun et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Bedaquiline susceptibility testing ofMycobacterium tuberculosisin an automated liquid culture system
- (2015) Gabriela Torrea et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Diagnostic Performance of the New Version (v2.0) of GenoType MTBDRslAssay for Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs: a Multicenter Study
- (2015) Elisa Tagliani et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Transformative tools for tackling tuberculosis
- (2015) Jennifer L. Gardiner et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Biomarkers for Tuberculosis Based on Secreted, Species-Specific, Bacterial Small Molecules
- (2015) Shih-Jung Pan et al. JOURNAL OF INFECTIOUS DISEASES
- Pharmacokinetic-Pharmacodynamic and Dose-Response Relationships of Antituberculosis Drugs: Recommendations and Standards for Industry and Academia
- (2015) Tawanda Gumbo et al. JOURNAL OF INFECTIOUS DISEASES
- Clinical value of whole-genome sequencing of Mycobacterium tuberculosis
- (2015) Howard E Takiff et al. LANCET INFECTIOUS DISEASES
- Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study
- (2015) Timothy M Walker et al. LANCET INFECTIOUS DISEASES
- Simultaneous staining of sputum smears for acid-fast and lipid-containing Myobacterium tuberculosis can enhance the clinical evaluation of antituberculosis treatments
- (2015) Xavier A. Kayigire et al. TUBERCULOSIS
- Role of therapeutic drug monitoring in pulmonary infections: use and potential for expanded use of dried blood spot samples
- (2015) Susan Hofman et al. Bioanalysis
- IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection
- (2015) Kristian Tonby et al. Scientific Reports
- Cytokine Kinetics in the First Week of Tuberculosis Therapy as a Tool to Confirm a Clinical Diagnosis and Guide Therapy
- (2015) Alice L. den Hertog et al. PLoS One
- High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa
- (2015) Abraham J. Niehaus et al. PLoS One
- Bedaquiline
- (2014) Elias B. Chahine et al. ANNALS OF PHARMACOTHERAPY
- Quantification of Rifapentine, a Potent Antituberculosis Drug, from Dried Blood Spot Samples Using Liquid Chromatographic-Tandem Mass Spectrometric Analysis
- (2014) Teresa L. Parsons et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Evaluation of Tuberculosis Viability Microscopy for Assessing Treatment Response
- (2014) S. Datta et al. CLINICAL INFECTIOUS DISEASES
- Acquired Drug Resistance: We Can Do More Than We Think!
- (2014) J.-W. C. Alffenaar et al. CLINICAL INFECTIOUS DISEASES
- Extensive Drug Resistance Acquired During Treatment of Multidrug-Resistant Tuberculosis
- (2014) J. Peter Cegielski et al. CLINICAL INFECTIOUS DISEASES
- Rapid diagnosis of pyrazinamide-resistant multidrug-resistant tuberculosis using a molecular-based diagnostic algorithm
- (2014) S.O. Simons et al. CLINICAL MICROBIOLOGY AND INFECTION
- Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection
- (2014) M. Pai et al. CLINICAL MICROBIOLOGY REVIEWS
- Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update
- (2014) Abdullah Alsultan et al. DRUGS
- Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement
- (2014) C. Lange et al. EUROPEAN RESPIRATORY JOURNAL
- The early bactericidal activity of antituberculosis drugs
- (2014) Andreas H Diacon et al. Expert Review of Anti-Infective Therapy
- Population pharmacokinetics and limited sampling strategy for first-line tuberculosis drugs and moxifloxacin
- (2014) C. Magis-Escurra et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Correlation of plasma anti-tuberculosis drug levels with subsequent development of hepatotoxicity
- (2014) A. Satyaraddi et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Clinical significance of 2 h plasma concentrations of first-line anti-tuberculosis drugs: a prospective observational study
- (2014) J. B. Prahl et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Re-Evaluation of the Critical Concentration for Ethambutol Antimicrobial Sensitivity Testing on the MGIT 960
- (2014) Sara Christianson et al. PLoS One
- Pharmacokinetics-Pharmacodynamics Analysis of Bicyclic 4-Nitroimidazole Analogs in a Murine Model of Tuberculosis
- (2014) Suresh B. Lakshminarayana et al. PLoS One
- Simultaneous determination of rifampicin, clarithromycin and their metabolites in dried blood spots using LC–MS/MS
- (2014) D.H. Vu et al. TALANTA
- Limited Sampling Strategies to Predict the Area Under the Concentration–Time Curve for Rifampicin
- (2014) Susanna E. Medellín-Garibay et al. THERAPEUTIC DRUG MONITORING
- Therapeutic drug monitoring in the treatment of tuberculosis: a retrospective analysis
- (2013) L. Van Tongeren et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Method for simultaneous analysis of nine second-line anti-tuberculosis drugs using UPLC-MS/MS
- (2013) M. Han et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots
- (2013) Lorena Baietto et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Efficacy of IP-10 as a biomarker for monitoring tuberculosis treatment
- (2013) Ji Young Hong et al. JOURNAL OF INFECTION
- Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes
- (2013) J. G. Pasipanodya et al. JOURNAL OF INFECTIOUS DISEASES
- Early Specific Host Response Associated with Starting Effective Tuberculosis Treatment in an Infection Controlled Placebo Controlled Mouse Study
- (2013) Alice L. den Hertog et al. PLoS One
- Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis
- (2013) Shuo Zhang et al. Emerging Microbes & Infections
- Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Linezolid in Patients with Multidrug-Resistant Tuberculosis
- (2012) D. H. Vu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis
- (2012) Kristian Ängeby et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Meta-Analysis of Clinical Studies Supports the Pharmacokinetic Variability Hypothesis for Acquired Drug Resistance and Failure of Antituberculosis Therapy
- (2012) Jotam G. Pasipanodya et al. CLINICAL INFECTIOUS DISEASES
- Dried Blood Spots: A New Tool for Tuberculosis Treatment Optimization
- (2012) D. H. Vu et al. CURRENT PHARMACEUTICAL DESIGN
- Early tuberculosis treatment monitoring by Xpert® MTB/RIF: Figure 1–
- (2012) Paolo Miotto et al. EUROPEAN RESPIRATORY JOURNAL
- Efficacy and safety of meropenem–clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB
- (2012) Saverio De Lorenzo et al. EUROPEAN RESPIRATORY JOURNAL
- Extension of the intensive phase reduces relapse but not failure in a regimen with rifampicin throughout
- (2012) K. J. M. Aung et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Can inhA mutation predict ethionamide resistance? [Short communication]
- (2012) V. Vadwai et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients
- (2012) W.-J. Koh et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Effect of Standard Tuberculosis Treatment on Plasma Cytokine Levels in Patients with Active Pulmonary Tuberculosis
- (2012) Catherine Riou et al. PLoS One
- Wild-Type MIC Distributions Must Be Considered To Set Clinically Meaningful Susceptibility Testing Breakpoints for All Bacterial Pathogens, Including Mycobacterium tuberculosisAuthors' Reply
- (2011) Kristian Ängeby et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Detection of Mutations Associated with First- and Second-Line Drug Resistance Compared with Conventional Drug Susceptibility Testing of Mycobacterium tuberculosis
- (2011) Patricia J. Campbell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The ins and outs of Mycobacterium tuberculosis drug susceptibility testing
- (2011) E.C. Böttger CLINICAL MICROBIOLOGY AND INFECTION
- Dynamics of interferon-gamma release assay and cytokine profiles in blood and respiratory tract specimens from mice with tuberculosis and the effect of therapy
- (2011) J. E. M. Steenwinkel et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experience
- (2011) A. D. Pranger et al. EUROPEAN RESPIRATORY JOURNAL
- Evaluation of the Genotype® MTBDRplus assay as a tool for drug resistance surveys
- (2011) L. Rigouts et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients
- (2011) A. H. Diacon et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Determination of moxifloxacin in dried blood spots using LC–MS/MS and the impact of the hematocrit and blood volume
- (2011) D.H. Vu et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Molecular Bacterial Load Assay, a Culture-Free Biomarker for Rapid and Accurate Quantification of Sputum Mycobacterium tuberculosis Bacillary Load during Treatment
- (2011) Isobella Honeyborne et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Multidrug-Resistant Tuberculosis Not Due to Noncompliance but to Between-Patient Pharmacokinetic Variability
- (2011) Shashikant Srivastava et al. JOURNAL OF INFECTIOUS DISEASES
- Limited-Sampling Strategies for Therapeutic Drug Monitoring of Moxifloxacin in Patients With Tuberculosis
- (2011) Arianna D Pranger et al. THERAPEUTIC DRUG MONITORING
- Dried blood spots, pharmacokinetic studies and better medicines for children
- (2011) Hitesh C Pandya et al. Bioanalysis
- Simple Rapid Near-Patient Diagnostics for Tuberculosis Remain Elusive—Is a “Treat-to-Test” Strategy More Realistic?
- (2011) Alice L. den Hertog et al. PLoS Pathogens
- New Susceptibility Breakpoints for First-Line Antituberculosis Drugs Based on Antimicrobial Pharmacokinetic/Pharmacodynamic Science and Population Pharmacokinetic Variability
- (2010) T. Gumbo ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of the Pharmacokinetics of Two Dosage Regimens of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Patients
- (2010) Jan-Willem C. Alffenaar et al. CLINICAL PHARMACOKINETICS
- In vitro pharmacokinetic/pharmacodynamic models in anti-infective drug development: focus on TB
- (2010) Pavan K Vaddady et al. Future Medicinal Chemistry
- Drogas antituberculose: interações medicamentosas, efeitos adversos e utilização em situações especiais - parte 2: fármacos de segunda linha
- (2010) Marcos Abdo Arbex et al. Jornal Brasileiro de Pneumologia
- Detection by GenoType MTBDRsl Test of Complex Mechanisms of Resistance to Second-Line Drugs and Ethambutol in Multidrug-Resistant Mycobacterium tuberculosis Complex Isolates
- (2010) F. Brossier et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
- (2010) Catharina C. Boehme et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Utility of a Commercial LAM-ELISA Assay for TB Diagnosis in HIV-Infected Patients Using Urine and Sputum Samples
- (2010) Keertan Dheda et al. PLoS One
- Limited Sampling Strategies for Therapeutic Drug Monitoring of Linezolid in Patients With Multidrug-Resistant Tuberculosis
- (2010) Jan-Willem C Alffenaar et al. THERAPEUTIC DRUG MONITORING
- Pharmacokinetics-Pharmacodynamics of Pyrazinamide in a Novel In Vitro Model of Tuberculosis for Sterilizing Effect: a Paradigm for Faster Assessment of New Antituberculosis Drugs
- (2009) T. Gumbo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosis
- (2009) J. F. Djoba Siawaya et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Isoniazid, Rifampin, Ethambutol, and Pyrazinamide Pharmacokinetics and Treatment Outcomes among a Predominantly HIV‐Infected Cohort of Adults with Tuberculosis from Botswana
- (2009) Sekai Chideya et al. CLINICAL INFECTIOUS DISEASES
- A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis
- (2009) G. B. Migliori et al. EUROPEAN RESPIRATORY JOURNAL
- Mycobacterium tuberculosis Strains with Highly Discordant Rifampin Susceptibility Test Results
- (2009) A. Van Deun et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Feasibility of the GenoType MTBDRsl Assay for Fluoroquinolone, Amikacin-Capreomycin, and Ethambutol Resistance Testing of Mycobacterium tuberculosis Strains and Clinical Specimens
- (2009) D. Hillemann et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis
- (2008) M. Ruhwald et al. EUROPEAN RESPIRATORY JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started